Islet Complex Lipids
Involvement in the Actions of Group VIA Calcium-Independent Phospholipase A2 in β-Cells
- Sasanka Ramanadham1,
- Haowei Song1,
- Shunzhong Bao1,
- Fong-Fu Hsu1,
- Sheng Zhang1,
- Zhongmin Ma2,
- Chun Jin1 and
- John Turk1
- 1Mass Spectrometry Resource, Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri
- 2Mount Sinai School of Medicine, New York, New York
- Address correspondence and reprint requests to Sasanka Ramanadham, Washington University School of Medicine, Department of Medicine, Box 8127, 660 S. Euclid Ave., St. Louis, MO 63110. E-mail: sramanad{at}im.wustl.edu
Abstract
The β-isoform of group VIA calcium-independent phospholipase A2 (iPLA2β) does not require calcium for activation, is stimulated by ATP, and is sensitive to inhibition by a bromoenol lactone suicide substrate. Several potential functions have been proposed for iPLA2β. Our studies indicate that iPLA2β is expressed in β-cells and participates in glucose-stimulated insulin secretion but is not involved in membrane phospholipid remodeling. If iPLA2β plays a signaling role in glucose-stimulated insulin secretion, then conditions that impair iPLA2β functions might contribute to the diminished capacity of β-cells to secrete insulin in response to glucose, which is a prominent characteristic of type 2 diabetes. Our recent studies suggest that iPLA2β might also participate in β-cell proliferation and apoptosis and that various phospholipid-derived mediators are involved in these processes. Detailed characterization of the iPLA2β protein level reveals that β-cells express multiple isoforms of the enzyme, and our studies involve the hypothesis that different isoforms have different functions.
- 12-HETE, 12-hydroxy-(5,8,10,14)-eicosatetraenoic acid
- BEL, bromoenol lactone
- CT, CTP:phosphocholine cytidyltransferase
- ER, endoplasmic reticulum
- iNOS, inducible nitric oxide synthase
- iPLA2β, β-isoform of group VIA calcium-independent phospholipase A2
- LPA, lysophosphatidic acid
- OE, overexpressing
- PLA2, phospholipase A2
Footnotes
-
This article is based on a presentation at a symposium. The symposium and the publication of this article were made possible by an unrestricted educational grant from Les Laboratoires Servier.
-
- Accepted May 6, 2003.
- Received March 14, 2003.
- DIABETES











